gamma-aminobutyric acid has been researched along with Hypermyotonia in 3 studies
gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report two cases of infants with NI, identified to have significant improvement in apnea following empiric treatment with gabapentin for presumed central pain and/or visceral hyperalgesia." | 7.79 | Treatment with gabapentin associated with resolution of apnea in two infants with neurologic impairment. ( Hauer, J; Mackey, D, 2013) |
| " This secondary hypertonia may contribute to apnea as a result of alterations in airway tone and chest wall movement." | 7.79 | Treatment with gabapentin associated with resolution of apnea in two infants with neurologic impairment. ( Hauer, J; Mackey, D, 2013) |
| "Infants with NI and apnea should have careful pain assessment and treatment, when considering other causes and interventions for apnea." | 7.79 | Treatment with gabapentin associated with resolution of apnea in two infants with neurologic impairment. ( Hauer, J; Mackey, D, 2013) |
| "We report two cases of infants with NI, identified to have significant improvement in apnea following empiric treatment with gabapentin for presumed central pain and/or visceral hyperalgesia." | 3.79 | Treatment with gabapentin associated with resolution of apnea in two infants with neurologic impairment. ( Hauer, J; Mackey, D, 2013) |
| " This secondary hypertonia may contribute to apnea as a result of alterations in airway tone and chest wall movement." | 3.79 | Treatment with gabapentin associated with resolution of apnea in two infants with neurologic impairment. ( Hauer, J; Mackey, D, 2013) |
| "Infants with NI and apnea should have careful pain assessment and treatment, when considering other causes and interventions for apnea." | 3.79 | Treatment with gabapentin associated with resolution of apnea in two infants with neurologic impairment. ( Hauer, J; Mackey, D, 2013) |
| " The median daily dosage of progabide was 24." | 2.65 | The clinical effect of the GABA-agonist, progabide, on spasticity. ( Mondrup, K; Pedersen, E, 1984) |
| "16 patients with spasticity in a stationary phase completed the trial." | 2.65 | The clinical effect of the GABA-agonist, progabide, on spasticity. ( Mondrup, K; Pedersen, E, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Mu, JD | 1 |
| Ma, LX | 1 |
| Zhang, Z | 1 |
| Yu, WY | 1 |
| Sun, TY | 1 |
| Qian, X | 1 |
| Tian, Y | 1 |
| Wang, JX | 1 |
| Hauer, J | 1 |
| Mackey, D | 1 |
| Mondrup, K | 1 |
| Pedersen, E | 1 |
1 trial available for gamma-aminobutyric acid and Hypermyotonia
| Article | Year |
|---|---|
The clinical effect of the GABA-agonist, progabide, on spasticity.
Topics: Adult; Arm; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Female; gamma-Aminobutyric Acid | 1984 |
2 other studies available for gamma-aminobutyric acid and Hypermyotonia
| Article | Year |
|---|---|
Acupuncture alleviates spinal hyperreflexia and motor dysfunction in post-ischemic stroke rats with spastic hypertonia via KCC2-mediated spinal GABA
Topics: Acupuncture Therapy; Animals; gamma-Aminobutyric Acid; Humans; Ischemic Stroke; Muscle Hypertonia; M | 2022 |
Treatment with gabapentin associated with resolution of apnea in two infants with neurologic impairment.
Topics: Amines; Analgesics; Apnea; Central Nervous System; Cyclohexanecarboxylic Acids; Female; Gabapentin; | 2013 |